Home » World Health Organization (WHO) » Page 18

World Health Organization (WHO)

CND Side event hosted by Norway and Australia Missions: The Global Crisis of Untreated Pain

Opened by Chair of CND, Amb. Srisamoot. Amb. Srisamoot. Thanked Amb. Hansen (Norway) and Amb. Stewart (Australia) for convening the panel. Other specialized agencies from UNODC, WHO and civil society. CND has had numerous sessions where we have talked about availability of controlled medicines and this event serves to reinforce and highlight the importance of …

Read more

CND Day 1 – Agenda Item 6 (d): International cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion

INCB President – 75% of the world’s population live without access to proper pain relief medication. In 1961, the international community committed to make adequate provisions to ensure access to pain medication while tackling diversion for illicit use. Addressing discrepancies in availability of controlled medicines is the responsibilities of governments due to their obligations under …

Read more

CND Day 1 – Agenda item 6(a): Challenges and future work of the CND and the WHO in the review of substances for possible scheduling recommendations

The goal is to assist states in applying the procedures as outlined in the three drug conventions. E/CN.7/2014/10 outlines the relevant provisions of the drug control conventions for scheduling. UNODC – By December 2014, the number of NPS reported by NPS rose to over 540 substances. The global spread of these substances have also increased …

Read more

CND Day 1 – Agenda item 6(b): Change in the scope of control of substances

Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …

Read more